Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

2seventy bio Q1 EPS $0.01 Beats $(0.12) Estimate, Sales $22.94M Beat $13.96M Estimate

Author: Benzinga Newsdesk | May 07, 2025 03:14pm
2seventy bio (NASDAQ:TSVT) reported quarterly earnings of $0.01 per share which beat the analyst consensus estimate of $(0.12) by 108.33 percent. This is a 101.23 percent increase over losses of $(0.81) per share from the same period last year. The company reported quarterly sales of $22.94 million which beat the analyst consensus estimate of $13.96 million by 64.28 percent. This is a 84.46 percent increase over sales of $12.44 million the same period last year.

Posted In: TSVT


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist